Active substance
Human rho immune globulin
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| IGAMAD 750 IU/ml Solution for Injection | 750 IU/ml | Solution for injection · Intramuscular use | 1 Vial | SAR 251.15 | Biological · Prescription | INSTITUTO GRIFOLS | Valid |
| D-GAM 1500 IU VAIL | 1250 IU/ml | Solution · Intravenous use | 1 Vial | SAR 408.35 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
| D-GAM 2500IU VIAL | 125 IU | Solution · Intravenous use | 1 Vial | SAR 726.00 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
| D-GAM 500IU VIAL | 250 IU/ml | Solution for injection · Intravenous use | 1 Vial | SAR 208.70 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
MATERNAL AND CHILD HEALTHCARE-UNEXPLAINED VAGINAL BLEEDING AFTER 13 WEEKS
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.